Skip to content
★ Sign in to follow
PL

Peter Lamb

Directeur Exécutif, Stratégie Scientifique et Directeur Scientifique
Total declarations
168
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (29 ops.)
€25.9M

Latest filing published 16 Dec 2022 for Exelixis, INC., €297k.

Filing timeline

BuySale
Peter Lamb

Insider track record

Disclosed buys
0
Disclosed sells
29
Signal history

Peter Lamb: trading record in brief

Peter Lamb (chief executive) discloses dealings in Exelixis, Inc. to SEC (Form 4). In total, 168 filings cover trades dated from 15 February 2011 to 15 December 2022.

Sales make up the whole of the open-market record (29 sales, €25.9M). Outside the open market, there are 61 share grants and 78 option exercises. In 2022 alone, the filings show no purchases and 1 sale.

The newest entry dates from 16 December 2022: an open-market sale of €297k, in Exelixis, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Peter Lamb

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations168 total
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    317,600 USD23SEC
    20,000 shares@ US$15.880.9% of flowCommon StockSEC:0000939767-22-000122:1
  • ◇
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    84,000 USD12SEC
    20,000 shares@ US$4.205.6% of flowCommon StockSEC:0000939767-22-000122:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    119,928 USD12SEC
    7,177 shares@ US$16.718.3% of flowCommon StockSEC:0000939767-22-000113:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    154,234 USD11SEC
    7,177 shares@ US$21.490.5% of flowCommon StockSEC:0000939767-22-000087:1
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    0SEC
    28,950 shares0Common StockSEC:0000939767-22-000087:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    122,950 USD12SEC
    6,123 shares@ US$20.088.5% of flowCommon StockSEC:0000939767-22-000061:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    0SEC
    59,490 shares0Common StockSEC:0000939767-22-000035:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    328,132 USD11SEC
    17,651 shares@ US$18.590.9% of flowCommon StockSEC:0000939767-22-000021:1
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    46,958 USD11SEC
    2,526 shares@ US$18.593.0% of flowCommon StockSEC:0000939767-22-000021:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    78,982 USD11SEC
    4,646 shares@ US$17.000.2% of flowCommon StockSEC:0000939767-21-000115:1
  • ◇
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    294,975 USD11SEC
    47,500 shares@ US$6.210.8% of flowCommon StockSEC:0000939767-21-000115:2
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    828,400 USD26SEC
    47,500 shares@ US$17.442.3% of flowCommon StockSEC:0000939767-21-000115:3
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    0SEC
    18,741 shares0Common StockSEC:0000939767-21-000115:0
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    859,275 USD23SEC
    47,500 shares@ US$18.092.3% of flowCommon StockSEC:0000939767-21-000100:1
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    123,406 USD11SEC
    6,818 shares@ US$18.100.3% of flowCommon StockSEC:0000939767-21-000100:2
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    42,046 USD11SEC
    2,323 shares@ US$18.100.1% of flowCommon StockSEC:0000939767-21-000100:3
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    959,698 USD11SEC
    53,022 shares@ US$18.102.6% of flowCommon StockSEC:0000939767-21-000100:4
  • ◇
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    294,975 USD13SEC
    47,500 shares@ US$6.2118.4% of flowCommon StockSEC:0000939767-21-000100:0
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    1M USD26SEC
    47,500 shares@ US$21.922.8% of flowCommon StockSEC:0000939767-21-000089:1
  • ◇
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    294,975 USD13SEC
    47,500 shares@ US$6.2118.2% of flowCommon StockSEC:0000939767-21-000089:0
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    148,062 USD11SEC
    7,177 shares@ US$20.630.4% of flowCommon StockSEC:0000939767-21-000084:1
  • ◆
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    0SEC
    28,950 shares0Common StockSEC:0000939767-21-000084:0
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    971,850 USD23SEC
    47,500 shares@ US$20.462.5% of flowCommon StockSEC:0000939767-21-000081:1
  • ◇
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    294,975 USD13SEC
    47,500 shares@ US$6.2117.9% of flowCommon StockSEC:0000939767-21-000081:0
  • ▼
    EVP, Scientific Strategy & CSOExecutivesExelixis, Inc.
    1M USD11SEC
    55,000 shares@ US$18.442.6% of flowCommon StockSEC:0000939767-21-000079:1

25 of 168 declarations